| Date | Name | Shares | Transaction | Value |
|---|
|
Oct 6, 2026
| Robert N. Duelks Director |
21,231
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Trish A. Mosconi Director |
823
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Amit K. Zavery Director |
9,252
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Richard J. Stingi Corporate VP and CHRO |
6,572
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $161.15 per share |
1,059,077.80
|
|
Oct 6, 2026
| Trish A. Mosconi Director |
824
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Amit K. Zavery Director |
9,225
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Thomas Patrick Carey Corporate VP |
8,800
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $159.76 per share |
1,405,888.00
|
|
Oct 6, 2026
| Maura A. Markus Director |
33,124
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Maura A. Markus Director |
33,087
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Ashima Ghei CFO |
6,433
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Oct 6, 2026
| Ashima Ghei CFO |
6,286
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $161.15 per share |
1,012,988.90
|
|
Oct 6, 2026
| Annette L. Nazareth Director |
9,834
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Annette L. Nazareth Director |
9,816
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Douglas Richard DeSchutter Co-President ICS |
17,136
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $161.15 per share |
2,761,466.40
|
|
Oct 6, 2026
| Eileen Katherine Murray Director |
6,185
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Eileen Katherine Murray Director |
6,167
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Christopher J. Perry President; Director |
49,385
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $161.15 per share |
7,958,392.75
|
|
Oct 6, 2026
| Melvin L. Flowers Director |
2,712
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 6, 2026
| Timothy C. Gokey CEO; Director |
159,159
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $161.15 per share |
25,648,472.85
|
|
Oct 6, 2026
| Ashima Ghei CFO |
6,118
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $161.15 per share |
985,915.70
|